HERlab is a company headquartered in the United Kingdom.
HERlab develops a high-throughput platform that combines a diverse library of unconventional microorganisms with AI (including LLM guidance) to identify and engineer optimal microbial expression systems for producing complex proteins with challenging folding and post-translational modifications. They generate datasets from these experiments to support protein design and biomanufacturing applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.